Table 4

- Laboratory values of 100 RA patients and 154 age-gender matched control subjects.

Laboratory valuesControlsRA patientsP-valuesCI
Antibodies profile
ANA, n (%)7 (4.5)8 (8.0)0.29-
RF positivity, n (%)4 (3.0)72 (72.0)0.00*-
RF level8.48±8.0650.61±115.220.00*14.65-41.25
Anti-CCP level, n (%)0 (0.0)46 (46.0)0.00*-
Thyroid function test
FT4 (pmol/L)15.59±3.6115.557±2.630.9415.11-16.05
FT3 (pmol/L)4.57±1.044.36±0.8170.244.31-4.67
TSH (mlU/L)2.02±1.562.98±4.480.03*1.96-2.84
Thyroglobulin29.13±38.0856.53±118.650.2117.29-57.83
TPO135.47±303.3747.92±75.290.1452.21-161.72
Blood rheology
RBC (10(6)/mcL)4.70±0.514.54±0.610.04*4.56-4.71
Hb (g/dl)12.49±1.6112.26±1.440.2812.19-12.61
HCT (%)38.36±4.6537.78±4.130.3337.53-38.72
MCV(fL)82.35±9.2984.51±8.030.0782.06-84.45
MCH (pg)27.22±4.8627.36±3.090.826.71-27.84
MCHC (g/dL)32.37±1.7832.33±1.190.8432.15-32.57
RDW14.34±2.2914.93±2.790.0914.24-14.93
Plt (103/mcL)262.35±70.93287.64±87.630.02*262.47-283.75
MPV9.42±1.448.67±1.230.00*8.91-9.29
WCC (103/mcL)6.83±1.918.21±3.290.00*7.06-7.78
Neutrophil count (%)53.78±11.7858.31±12.390.01*54.06-57.34
Neutrophil absolute (103/mcL)3.76±1.744.96±2.580.00*3.97-4.56
Lymphocyte count (%)35.27±10.1931.57±10.880.01*32.28-35.13
Lymphocyte absolute (103/mcL)2.32±0.682.41±0.9470.362.25-2.47
Monocyte count (%)7.42±3.147.12±1.900.436.93-7.66
Monocyte absolute (103/mcL)0.51±0.210.58±0.230.02*0.51-0.57
Eosinophil count (%)0.19±0.130.19±0.130.920.17-0.21
Eosinophil absolute (103/mcL)0.19±0.130.21±0.160.650.18-0.22
Basophil count (%)0.49±0.380.44±0.310.260.43-0.52
Basophil absolute (103/mcL)0.03±0.040.04±0.030.520.03-0.04
Inflammatory markers
ESR (mm/hr)23.78±17.5332.75±25.660.00*24.69-30.57
CRP (mg/dl)4.81±6.5916.66±34.090.00*6.68-13.17
Renal function
Creatinine (mmol/L)61.10±34.6960.08±22.940.856.58-64.76
Urea (mmol/L)4.88±6.264.01±1.690.23.86-5.18
Uric acid (µmol/L)290.56±90.69265.74±106.620.07266.45-293.29
eGFR (ml/min)96.70±11.6786.71±28.640.2585.25-101.79
Urine microalbumin level21.12±110.054.87±17.790.25-2.22, 25.32
Glucose status
Glucose fasting (mmol/L)5.96±1.526.93±4.710.04*5.89-6.82
HbA1C (mmol/mol)6.20±1.146.76±1.850.03*6.14-6.65
Liver function test
Total protein74.62±5.7972.65±6.200.02*72.96-74.63
Albumin39.91±4.7338.48±4.710.03*38.65-39.96
Bilirubin (total)10.65±7.419.89±4.680.49.45-11.21
ALT26.30±22.2623.08±16.040.2522.19-27.67
Alkaline phosphatase72.85±24.1871±21.790.5768.86-75.26
Electrolytes
Calcium2.32±0.132.29±0.120.252.29-2.33
Phosphates1.17±0.161.12±0.210.21.10-1.18
Magnesium0.81±0.060.76±0.010.03*0.77-0.82
Iron study
Ferritin (ng/ mL)64.81±117.4775.73±77.190.5452.06-87.95
Iron (µmol/L)11.03±5.6110.75±5.350.789.89-11.91
Transferrin (mg/dl)257.01±85.61269.87±55.870.36249.65-277.87
Lipid profile
Cholesterol (mmol/L)4.56±1.024.67±1.080.444.46-4.75
Triglycerides (mmol/L)1.24±0.661.32±0.760.411.17-1.37
HDL (mmol/L)1.36±0.731.31±0.460.561.25-1.43
LDL (mmol/L)2.76±0.962.70±0.920.692.59-2.87
Other tests
Vitamin D (nmol/l)69.26±36.9154.82±33.620.01*58.34-68.88

Values are presented as mean ± standrad deviation (SD).

RA: rheumatoid arthritis,

CI: confidence interval, ANA: antinuclear antibodies, anti-DNAase: anti-double strand antibodies,

RF: rheumatoid factor, anti-CCP: anti-citrullinated peptide, ASMA: anti-smooth muscles antibody,

anti Scl 70: anti-scleroderma 70, anti-RNP: anti-ribonuclear protein, anti-Sm: anti Smith antibody,

FT: free thyroxine, Ft3: free triiodothyronine, TPO: thyroid peroxidase, RBC: red blood cells (106/mcL),

Hb: hemoglobin (g/dl), Hct: hematocrit, MCV: mean cell volume (fL), MCH: mean cell hemoglobin (pg),

MCHC: mean cell hemoglobin concentration (32-36 g/dL), RDW: red cell distribution width, Plt: platelet (103/mcL), MPV: mean platelet volume (9.4-12.3 fL), WCC: white cell counts (103/mcL), ESR: erythrocytes sedimentation rate (mm/min), CRP: C-reactive protein (mg/dl), eGFR: estimated glomerular filtration rate (ml/min),

HbA1C: glycosylated hemoglobin (mmol/mol), ALT; alanine transferase (IU/L), HDL: high density,

LDL: low density lipoprotein (mmol/L)

  • * P-value of <0.05.